These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31268032)

  • 1. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
    Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
    Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Chaudhry A; Roels C; Lee J
    Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
    Osafehinti DA; Okoli OJ; Karam JG
    AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
    Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
    Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases.
    Goto S; Ishikawa JY; Idei M; Iwabuchi M; Namekawa M; Nomura T
    Am J Case Rep; 2021 Mar; 22():e929773. PubMed ID: 33723205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
    Brown F; McColl T
    J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic diabetic ketoacidosis following traumatic brain injury.
    Jang SW; Lee H
    Am J Emerg Med; 2024 Mar; 77():232.e1-232.e3. PubMed ID: 38216364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor.
    Miwa M; Nakajima M; Kaszynski RH; Goto H
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33028568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Allison R; Goldstein D; Musso MW
    J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycemic Diabetic Ketoacidosis: A Review.
    Modi A; Agrawal A; Morgan F
    Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
    Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M
    Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
    Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
    Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.
    Bader N; Mirza L
    Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.